Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103816 · ClinicalTrials.gov registry record · NA
The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02103816 is a NA study that has completed, run by Cynosure. The registered enrollment target is 21 participants.
The verdict
NCT02103816, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study to evaluate the SmartLipo Triplex laser system along with the SideLaze800 hand piece in the treatment of Acne Scars.
Interventions
- DEVICE SmartLipo Triplex laser system along with the SideLaze800 hand piece
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02103816
The ClinicalTrials.gov registry entry for NCT02103816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmartLipo Triplex laser system along with the SideLaze800 hand piece is the first listed.
NCT02103816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02103816 about?
NCT02103816 is a clinical study titled "The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars". The purpose of this study to evaluate the SmartLipo Triplex laser system along with the SideLaze800 hand piece in the treatment of Acne Scars.
What is the current status of trial NCT02103816?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-10. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02103816?
The interventions under investigation include: SmartLipo Triplex laser system along with the SideLaze800 hand piece (DEVICE).
Who is sponsoring clinical trial NCT02103816?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.